These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 19332706)

  • 1. Aromatase inhibitors as adjuvant therapy for breast cancer.
    Montemurro F; Aglietta M; Del Mastro L
    J Clin Oncol; 2009 May; 27(15):2566-7. PubMed ID: 19332706
    [No Abstract]   [Full Text] [Related]  

  • 2. Reducing early recurrence with adjuvant aromatase inhibitors: what is the evidence?
    Dixon JM
    Breast; 2008 Aug; 17(4):353-60. PubMed ID: 18490163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absolute benefits of aromatase inhibitors in adjuvant treatment of breast cancer: should we know more?
    Seruga B; Ocana A; Niraula S; Amir E
    J Clin Oncol; 2010 Jul; 28(20):e346-7; author reply e348. PubMed ID: 20458046
    [No Abstract]   [Full Text] [Related]  

  • 4. Aromatase inhibitors as adjuvant therapy for breast cancer: overall survival versus disease-free survival as a primary end point in clinical practice.
    Sánchez-Muñoz A; Ribelles N; Márquez A; Pérez-Ruiz E; Alba E
    J Clin Oncol; 2009 Dec; 27(35):e255-6; author reply e257-8. PubMed ID: 19884520
    [No Abstract]   [Full Text] [Related]  

  • 5. The optimal duration of adjuvant hormonal therapy for early-stage breast cancer.
    Winer E
    Clin Adv Hematol Oncol; 2008 Aug; 6(8):573-4. PubMed ID: 18820598
    [No Abstract]   [Full Text] [Related]  

  • 6. Aromatase inhibitors for breast cancer prevention.
    Cuzick J
    J Clin Oncol; 2005 Mar; 23(8):1636-43. PubMed ID: 15755971
    [No Abstract]   [Full Text] [Related]  

  • 7. Personal breast: customizing agents and biomarkers for optimal adjuvant endocrine therapy.
    Bardia A; Stearns V
    Breast Cancer Res Treat; 2010 Apr; 120(2):437-9. PubMed ID: 20162380
    [No Abstract]   [Full Text] [Related]  

  • 8. Optimum use of aromatase inhibitors in the adjuvant treatment of early breast cancer.
    Buzdar AU; Cuzick J
    J Clin Oncol; 2005 Nov; 23(33):8544-6; author reply 8546-7. PubMed ID: 16293888
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparing aromatase inhibitors in the absence of clinical trial results can be misleading.
    Goldhirsch A; Price KN
    J Surg Oncol; 2007 Mar; 95(4):355-6; author reply 357. PubMed ID: 17192949
    [No Abstract]   [Full Text] [Related]  

  • 10. Aromatase inhibitors in breast cancer.
    Smith IE; Dowsett M
    N Engl J Med; 2003 Jun; 348(24):2431-42. PubMed ID: 12802030
    [No Abstract]   [Full Text] [Related]  

  • 11. Adjuvant endocrine therapy for perimenopausal women with early breast cancer.
    Ortmann O; Cufer T; Dixon JM; Maass N; Marchetti P; Pagani O; Pronzato P; Semiglazov V; Spano JP; Vrdoljak E; Wildiers H
    Breast; 2009 Feb; 18(1):2-7. PubMed ID: 19036588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aromatase inhibitors in advanced breast cancer].
    Spinelli GP; Tomao F; Miele E; Pasciuti G; Russillo M; Tomao S
    Recenti Prog Med; 2008 Jan; 99(1):34-8. PubMed ID: 18389871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current topics and perspectives on the use of aromatase inhibitors in the treatment of breast cancer.
    Iwase H
    Breast Cancer; 2008; 15(4):278-90. PubMed ID: 18810576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The similarities of aromatase inhibitors outweigh the differences.
    Jänicke F
    Anticancer Drugs; 2008 Mar; 19 Suppl 2():S7-9. PubMed ID: 18337642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant endocrine therapy in post menopausal women: pharmacological evaluation using decision analysis approach in a Japanese hospital setting.
    Miyazaki Y; Arakawa I; Inoue T
    Gan To Kagaku Ryoho; 2009 Aug; 36(8):1299-309. PubMed ID: 19692769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Aromatase inhibitors in breast cancer therapy].
    Joensuu H
    Duodecim; 2004; 120(11):1301-4. PubMed ID: 15327081
    [No Abstract]   [Full Text] [Related]  

  • 17. [Is our current knowledge sufficient for the up-front use of aromatase inhibitors as adjuvant therapy for breast cancer?].
    Lefebvre-Lacoeuille C; Catala L; Descamps P
    J Gynecol Obstet Biol Reprod (Paris); 2009 Oct; 38(6):453-5. PubMed ID: 19640658
    [No Abstract]   [Full Text] [Related]  

  • 18. Medical treatment of early breast cancer. I: adjuvant treatment.
    Smith I; Chua S
    BMJ; 2006 Jan; 332(7532):34-7. PubMed ID: 16399737
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hormonal therapy in breast cancer].
    Espinós J; Reyna C; de la Cruz S; Oiler C; Hernández A; Fernández Hidalgo O; Santisteban M; García Foncillas J
    Rev Med Univ Navarra; 2008; 52(1):40-8. PubMed ID: 18578196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aromatase inhibitors in breast cancer.
    Hiscox S; Davies EL; Barrett-Lee P
    Maturitas; 2009 Aug; 63(4):275-9. PubMed ID: 19577386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.